These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 20030925)

  • 1. [Construction of expression plasmid for fused idiotypic DNA vaccine of B-cell lymphoma].
    Wang FX; Zhang Y; Zhao B; Pan L; Zhang XJ; Luo JM; Dong ZR
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Dec; 17(6):1453-8. PubMed ID: 20030925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Construction and expression of a prokaryotic expression plasmid of idiotypic vaccine against B cell lymphoma: encoding the fusion genes of single-chain variable fragment and MCP-3].
    Wang FX; Zhao B; Cheng YH; Pan L; Luo JM; Zhang XJ; Dong ZR
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Dec; 14(6):1151-5. PubMed ID: 17204183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The experimental study on idiotypic DNA vaccine against human B-cell lymphoma to induce antitumor immune response].
    Zhong KL; Zhang WJ; Yuan Y; Wu Y; Zhang MW; Mao N
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2003 Dec; 11(6):609-15. PubMed ID: 14706145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Specific humoral immune response against B-cell lymphoma elicited by mixed immunoglobulin fragments].
    Lin N; Zhu P; Zhang X; Dong Y; Ren Y; Wang Y; Li W
    Zhonghua Yi Xue Za Zhi; 2002 Jun; 82(11):766-70. PubMed ID: 12126549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibodies elicited by naked DNA vaccination against the complementary-determining region 3 hypervariable region of immunoglobulin heavy chain idiotypic determinants of B-lymphoproliferative disorders specifically react with patients' tumor cells.
    Rinaldi M; Ria F; Parrella P; Signori E; Serra A; Ciafrè SA; Vespignani I; Lazzari M; Farace MG; Saglio G; Fazio VM
    Cancer Res; 2001 Feb; 61(4):1555-62. PubMed ID: 11245465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Construction of a DNA vaccine against human B cell lymphoma].
    Zhang YS; Zhong KL; Yuan Y; Zhang MW; Zhang Y; Mao N
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2004 Jan; 20(1):79-82. PubMed ID: 15182628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunization with a recombinant adenovirus encoding a lymphoma idiotype: induction of tumor-protective immunity and identification of an idiotype-specific T cell epitope.
    Armstrong AC; Dermime S; Allinson CG; Bhattacharyya T; Mulryan K; Gonzalez KR; Stern PL; Hawkins RE
    J Immunol; 2002 Apr; 168(8):3983-91. PubMed ID: 11937555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-lymphoma immunity: relative efficacy of peptide and recombinant DNA vaccine.
    Lim SY; Laxmanan S; Stuart G; Ghosh SK
    Cancer Detect Prev; 2001; 25(5):470-8. PubMed ID: 11718453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Escherichia coli-based production of a tumor idiotype antibody fragment--tetanus toxin fragment C fusion protein vaccine for B cell lymphoma.
    Patel KG; Ng PP; Levy S; Levy R; Swartz JR
    Protein Expr Purif; 2011 Jan; 75(1):15-20. PubMed ID: 20851769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cloning variable region genes of clonal lymphoma immunoglobulin for generating patient-specific idiotype DNA vaccine.
    Cha SC; Qin H; Sakamaki I; Kwak L
    Methods Mol Biol; 2014; 1139():289-303. PubMed ID: 24619688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA vaccines against lymphoma: promotion of anti-idiotypic antibody responses induced by single chain Fv genes by fusion to tetanus toxin fragment C.
    Spellerberg MB; Zhu D; Thompsett A; King CA; Hamblin TJ; Stevenson FK
    J Immunol; 1997 Aug; 159(4):1885-92. PubMed ID: 9257853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-idiotypic DNA vaccines for lymphoma immunotherapy require the presence of both variable region genes for tumor protection.
    Benvenuti F; Burrone OR; Efremov DG
    Gene Ther; 2000 Apr; 7(7):605-11. PubMed ID: 10819576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA vaccines with single-chain Fv fused to fragment C of tetanus toxin induce protective immunity against lymphoma and myeloma.
    King CA; Spellerberg MB; Zhu D; Rice J; Sahota SS; Thompsett AR; Hamblin TJ; Radl J; Stevenson FK
    Nat Med; 1998 Nov; 4(11):1281-6. PubMed ID: 9809552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The experimental study on the idiotypic nucleic Acid vaccine constructed from the genomic DNA to lymphoma].
    Lin NJ; Zhu P; Zhang YP; Shi YJ; Zhang X; Bu DF; Dong YJ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2002 Apr; 10(2):126-30. PubMed ID: 12513814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Production of a single-chain fragment of the murine anti-idiotypic antibody ACA125 as phage-displayed and soluble antibody by recombinant phage antibody technique.
    Schlebusch H; Reinartz S; Kaiser R; Grünn U; Wagner U
    Hybridoma; 1997 Feb; 16(1):47-52. PubMed ID: 9085128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A genetic approach to idiotypic vaccination for B cell lymphoma.
    Stevenson FK; Zhu D; King CA; Ashworth LJ; Kumar S; Thompsett A; Hawkins RE
    Ann N Y Acad Sci; 1995 Nov; 772():212-26. PubMed ID: 8546396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunogenicity of a plasmid DNA vaccine encoding chimeric idiotype in patients with B-cell lymphoma.
    Timmerman JM; Singh G; Hermanson G; Hobart P; Czerwinski DK; Taidi B; Rajapaksa R; Caspar CB; Van Beckhoven A; Levy R
    Cancer Res; 2002 Oct; 62(20):5845-52. PubMed ID: 12384547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Development of IgHV family specific nucleic acid vaccine against lymphoma by construction of fusion gene of immunoglobulin heavy chain variable region and cytokine].
    Liu H; Zhu P; Lin NJ; Zhang Y; Bu DF; Wang YJ; Wang YQ; Yang Y
    Zhonghua Yi Xue Za Zhi; 2004 Jan; 84(1):48-53. PubMed ID: 14990159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prophylactic anti-tumor effects in a B cell lymphoma model with DNA vaccines delivered on polyethylenimine (PEI) functionalized PLGA microparticles.
    Pai Kasturi S; Qin H; Thomson KS; El-Bereir S; Cha SC; Neelapu S; Kwak LW; Roy K
    J Control Release; 2006 Jul; 113(3):261-70. PubMed ID: 16793161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The development of a bicistronic plasmid DNA vaccine for B-cell lymphoma.
    Singh G; Parker S; Hobart P
    Vaccine; 2002 Jan; 20(9-10):1400-11. PubMed ID: 11818159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.